The results of subsequent luciferase reporter assays not only indicated that the PKM2 promoter could interact with FOXA3 at predicted Site 1 but also revealed that FOXA3 acted as a transcriptional inhibitor of PKM2 in HCC cells (Fig. 8f). The gene discussed is FOXA3; the disease is hepatocellular carcinoma.